You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Plasma Cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Toripalimab (anti-programmed death-1 inhibitor)
  • +4 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

Relapsed/Refractory Diffuse Large B Cell Lymphoma, Relapsed/Refractory Primary Mediastinal B Cell Lymphoma, Relapsed/Refractory

Approved for marketing
  • Relapsed/Refractory Diffuse Large B Cell Lymphoma
  • +3 more
  • Axicabtagene Ciloleucel
  • Duarte, California
  • +14 more
Aug 30, 2022

Ischemic Heart Disease Trial in Miami, Louisville, Houston (umbilical cord-derived mesenchymal stromal cells (UC-MSCs))

Not yet recruiting
  • Ischemic Heart Disease
  • umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
  • Miami, Florida
  • +2 more
Nov 17, 2023

Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte (Quality-of-Life

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +21 more
  • Quality-of-Life Assessment
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2022

Heart Transplantation Trial in Madrid (Autologous thyTreg)

Recruiting
  • Heart Transplantation
  • Autologous thyTreg
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañon
Dec 5, 2022

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Nutritional Requirements Trial in Columbus (Zero hard-boiled egg at 0 h, One hard-boiled egg at 0 h, Two hard-boiled eggs at 0

Recruiting
  • Nutritional Requirements
  • Zero hard-boiled egg at 0 h
  • +5 more
  • Columbus, Ohio
    Ohio State University
Dec 16, 2022

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Completed
  • Small Cell Lung Cancer
  • atezolizumab
  • Chalon-sur-Saône, France
  • +1 more
Jan 5, 2023

Applanation Tonometry in the Diagnosis of Giant Cell Arteritis

Not yet recruiting
  • Giant Cell Arteritis
  • Applanation tonometry
  • Montreal, Quebec, Canada
    Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Jan 26, 2023

NSCLC, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab and neoadjuvant therapy, surgical resection of lung cancer)

Recruiting
  • NSCLC
  • Neoadjuvant Therapy
  • Serplulimab and neoadjuvant therapy
  • surgical resection of lung cancer
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
May 22, 2023

MDS Trial in France (Decitabine, HYDROXYUREA)

Completed
  • MDS
  • Saint-Denis, La Réunion, France
  • +44 more
Nov 17, 2021

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Hematology Biobank : Invitro Study of Blood Disorders

Recruiting
  • Hematological Disorders
    • Bronx, New York
      Montefiore Medical Center
    Nov 14, 2022

    Severe Sepsis Trial in London (Exercise)

    Completed
    • Severe Sepsis
    • Exercise
    • London, Ontario, Canada
      London Health Sciences Centre
    Jun 16, 2021

    Dilatation of Anastomosis, Bypass Complication, Obesity Trial in São José do Rio Prêto (Carbon dioxide, Ambient air, Argon

    Completed
    • Dilatation of Anastomosis
    • +2 more
    • Carbon dioxide
    • +2 more
    • São José do Rio Prêto, Sao Paolo, Brazil
      Kaiser Clinic and Day Hospital
    Aug 16, 2022

    Trial of Kidney Tx Patients Treated With Imlifidase or PE

    Recruiting
    • Kidney Transplant Rejection
    • Vienna, Austria
    • +4 more
    Apr 7, 2022

    Heart Failure Trial in Grand Rapids

    Recruiting
    • Heart Failure
      • Grand Rapids, Michigan
        Frederik Meijer Heart Center
      Nov 23, 2022

      NSCLC Trial (Almonertinib Envafolimab)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Almonertinib Envafolimab
      • (no location specified)
      Sep 10, 2022

      Lymphangioleiomyomatosis Trial in Spain (Loratadine, Placebo 10mg/day added to rapamycin for 12 months)

      Recruiting
      • Lymphangioleiomyomatosis
      • Loratadine
      • Placebo 10mg/day added to rapamycin for 12 months
      • Hospitalet de Llobregat, Barcelona, Spain
      • +5 more
      Jan 12, 2022

      Immune Activation asCause of Insulin Resistance in Adults Living

      Recruiting
      • HIV Infections
      • Signaling, metabolomic and transcriptomic analysis
      • Montpellier, Hérault, France
        Saint Eloi Hospital, University Hospital of Montpellier
      Feb 11, 2021

      Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seoul (cell free DNA in blood and urine,

      Recruiting
      • Pancreatic Cancer
      • +2 more
      • cell free DNA in blood and urine, metabolite/microbiome in urine and stool
      • Seoul, Korea, Republic of
      • +1 more
      Nov 2, 2022

      MALT Lymphoma Trial in France, Italy, Switzerland (Chlorambucil, Rituximab i.v., Rituximab s.c.)

      Active, not recruiting
      • MALT Lymphoma
      • Créteil, France
      • +37 more
      Nov 4, 2022

      Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

      Recruiting
      • Intracranial Meningioma
      • +2 more
      • Birmingham, Alabama
      • +707 more
      Sep 25, 2022

      Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Enoblituzumab, Retifanlimab,

      Recruiting
      • Head and Neck Cancer
      • +2 more
      • Enoblituzumab
      • +2 more
      • Baltimore, Maryland
      • +41 more
      May 16, 2022